IN2012DN00235A - - Google Patents
Info
- Publication number
- IN2012DN00235A IN2012DN00235A IN235DEN2012A IN2012DN00235A IN 2012DN00235 A IN2012DN00235 A IN 2012DN00235A IN 235DEN2012 A IN235DEN2012 A IN 235DEN2012A IN 2012DN00235 A IN2012DN00235 A IN 2012DN00235A
- Authority
- IN
- India
- Prior art keywords
- progression
- prevention
- delay
- treatment
- invention concerns
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22794009P | 2009-07-23 | 2009-07-23 | |
| PCT/EP2010/060733 WO2011009951A1 (en) | 2009-07-23 | 2010-07-23 | 1h-quinazoline-2, 4 -diones for use in the treatment of neuronal ceroid lipofuscinosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00235A true IN2012DN00235A (instruction) | 2015-05-01 |
Family
ID=42671655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN235DEN2012 IN2012DN00235A (instruction) | 2009-07-23 | 2010-07-23 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120122903A1 (instruction) |
| EP (1) | EP2456442A1 (instruction) |
| JP (1) | JP2012533605A (instruction) |
| KR (1) | KR20120052341A (instruction) |
| CN (1) | CN102470137A (instruction) |
| AU (1) | AU2010274921B2 (instruction) |
| BR (1) | BR112012001258A2 (instruction) |
| CA (1) | CA2768333A1 (instruction) |
| IN (1) | IN2012DN00235A (instruction) |
| MX (1) | MX2012000956A (instruction) |
| RU (1) | RU2012106426A (instruction) |
| WO (1) | WO2011009951A1 (instruction) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5976011B2 (ja) * | 2011-04-05 | 2016-08-23 | 武田薬品工業株式会社 | スルホンアミド誘導体およびその用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9400680D0 (en) * | 1994-01-14 | 1994-03-09 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB0416730D0 (en) * | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
| GB0507298D0 (en) * | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
-
2010
- 2010-07-23 KR KR1020127004575A patent/KR20120052341A/ko not_active Withdrawn
- 2010-07-23 EP EP10734746A patent/EP2456442A1/en not_active Withdrawn
- 2010-07-23 CN CN2010800334750A patent/CN102470137A/zh active Pending
- 2010-07-23 IN IN235DEN2012 patent/IN2012DN00235A/en unknown
- 2010-07-23 US US13/384,280 patent/US20120122903A1/en not_active Abandoned
- 2010-07-23 JP JP2012521055A patent/JP2012533605A/ja active Pending
- 2010-07-23 MX MX2012000956A patent/MX2012000956A/es not_active Application Discontinuation
- 2010-07-23 BR BR112012001258A patent/BR112012001258A2/pt not_active IP Right Cessation
- 2010-07-23 AU AU2010274921A patent/AU2010274921B2/en not_active Expired - Fee Related
- 2010-07-23 WO PCT/EP2010/060733 patent/WO2011009951A1/en active Application Filing
- 2010-07-23 RU RU2012106426/04A patent/RU2012106426A/ru not_active Application Discontinuation
- 2010-07-23 CA CA2768333A patent/CA2768333A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102470137A (zh) | 2012-05-23 |
| CA2768333A1 (en) | 2011-01-27 |
| JP2012533605A (ja) | 2012-12-27 |
| BR112012001258A2 (pt) | 2016-02-10 |
| US20120122903A1 (en) | 2012-05-17 |
| AU2010274921A1 (en) | 2012-02-02 |
| AU2010274921B2 (en) | 2014-08-14 |
| MX2012000956A (es) | 2012-02-28 |
| RU2012106426A (ru) | 2013-08-27 |
| WO2011009951A1 (en) | 2011-01-27 |
| EP2456442A1 (en) | 2012-05-30 |
| KR20120052341A (ko) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2349106T3 (pl) | System do leczenia męskiej dysfunkcji seksualnej | |
| GB201017345D0 (en) | Receptor antagonists | |
| WO2011009890A3 (en) | Use of azabicycloalkyl derivatives or pyrrolidine - 2 - one derivatives for the treatment or prevention of ataxia | |
| IL208895A0 (en) | Nmda receptor antagonists for the treatment of neuropsychiatric disorders | |
| LT2464362T (lt) | Probiotikų preparatas, skirtas šunų virškinamojo trakto sutrikimų prevencijai arba gydymui | |
| WO2011005942A3 (en) | Oligonucleotide-based compounds as inhibitors of toll-like receptors | |
| BR112012009576A2 (pt) | potencializador alostérico de mglur4, composições, e métodos de tratamento de disfunção neurológica | |
| DOP2007000068A (es) | Compuestos de amino-pirimidina 2,6-sustituidos-4-monosustituidos como antagonistas del receptor de prostaglandina d2 | |
| WO2008095086A3 (en) | Topiramate plus naltrexone for the treatment of addictive disorders | |
| IN2012DN00572A (instruction) | ||
| FR2951637B1 (fr) | Table pour massages de personnes allongees ou assises. | |
| MY150600A (en) | Use of opioid antagonists for treating urinary retention | |
| IL218971A0 (en) | Sulfoxide derivatives for the treatment of tumours | |
| PH12013501904A1 (en) | Pyridopyrazine derivatives and their use | |
| EP2411042A4 (en) | Tissue kallikrein for the treatment of pancreatic cell dysfunction | |
| EA201170700A1 (ru) | Тетразамещенные пиридазины в качестве антагонистов пути hedgehog | |
| GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
| IL206881A0 (en) | Formulations for the treatment of mucositis induced by antitumor or immunosuppressive therapy | |
| CL2012001606A1 (es) | Compuestos derivados de tiazoles bicíclicos como moduladores alostéricos de receptores mglur5; composición farmacéutica que los comprende; procedimiento de preparación de la composición farmacéutica; combinación farmacéutica; y uso del compuesto en la prevención, tratamiento o profilaxis de trastornos neurológicos o psiquiátricos. | |
| PH12017500910A1 (en) | Use of sigma receptor ligands in osteoarthritis | |
| GB0917745D0 (en) | Compositions for the prevention or treatment of migraine | |
| IN2012DN00235A (instruction) | ||
| UA96574C2 (ru) | Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции | |
| MX2014002693A (es) | Uso de 1h-quinazolina-2,4-dionas para usarse en la prevencion o el tratamiento de epilepsia fotosensible. | |
| SI2391366T1 (sl) | Substituirani benzimidazoli za zdravljenje astrocitomov |